Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock - $0.001 par value
-
Shares outstanding
-
10.6M
-
Number of holders
-
17
-
Total 13F shares, excl. options
-
4.66M
-
Shares change
-
-47.2K
-
Total reported value, excl. options
-
$8.02M
-
Value change
-
-$71.1K
-
Number of buys
-
6
-
Number of sells
-
-6
-
Price
-
$1.72
Significant Holders of NEPHROS INC - Common Stock - $0.001 par value (NEPH) as of Q1 2025
18 filings reported holding NEPH - NEPHROS INC - Common Stock - $0.001 par value as of Q1 2025.
NEPHROS INC - Common Stock - $0.001 par value (NEPH) has 17 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.66M shares
of 10.6M outstanding shares and own 43.88% of the company stock.
Largest 10 shareholders include WEXFORD CAPITAL LP (3.6M shares), Topline Capital Management, LLC (422K shares), VANGUARD GROUP INC (204K shares), BARD ASSOCIATES INC (143K shares), GEODE CAPITAL MANAGEMENT, LLC (90.3K shares), HighTower Advisors, LLC (55.7K shares), ELKHORN PARTNERS LIMITED PARTNERSHIP (38.9K shares), BLAIR WILLIAM & CO/IL (36.2K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (23.6K shares), and STATE STREET CORP (15.7K shares).
This table shows the top 17 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.